kidney disease glp-1 news Bariatric Surgery Surpasses Diabetes Medication in Progression of Disease: Study Finds GLP-1s in CKD: Evidence, market

Dive into the therapeutic potential of the Glucagon Receptor (GCGR) a class-B GPCR crucial for regulating hepatic glucose production and energy metabolism

In addition, activating GLP-1R protected mitochondria against the TGF-1+IL-1-induced increase in oxidative phosphorylation in fibroblasts

Managing GLP-1 Side Effects Through Smart Meal Prep The most common side effects of GLP-1 medications are nausea, constipation, bloating, and early satiety

As GLP-1 medications like Ozempic become more widely used, I think we need a more complete conversation around body composition and long-term health

Drugs targeting diabetes, obesity, and related metabolic diseases are taken chronically by very large patient []